1,101 posts by 291 firms and lawyers
Cannabis law explained by the lawyers who practise it: analysis and commentary from law firms around the world, with the Cannabis Law Journal.
President Trump has announced he will nominate Todd Blanche — his former personal attorney, who has been running the Department of Justice in an acting capacity — to serve as permanent attorney general.
RN Collins has written a series of 20 new articles for cannabis law report on 2026 Psychedelics & Legal Issues.
Dr. Marty Makary resigned as FDA commissioner last week, barely a year after his Senate confirmation. HHS Secretary Robert F. Kennedy Jr. confirmed the departure and indicated the agency is searching for a replacement.
The week of April 18 through April 23, 2026 produced two distinct and legally consequential federal actions on controlled substances. On April 18, President Trump signed Executive Order 14401, directing the federal government to…
As the frozen precipitation is continuing to thaw across the upper part of Mississippi, the Mississippi legislature continues to forge ahead in this year’s legislative session.
California’s current legislative session is now in full swing, bringing insight into the potential market shifts on the table for California’s cannabis, hemp, and psychedelic industries. February 21, 2025 was the deadline for…
Welcome to the Vicente LLP Federal and International Cannabis and Psychedelics Law & Policy update! In this quarterly newsletter, we will share selected insights, news and events to keep you in the loop on global cannabis, hemp…
Authored by By Jodi Green, Karina Bashir and Matt Brockmeier of Antithesis Law The psychedelic ecosystem stands at a critical juncture as businesses and advocates navigate complex legal landscapes.
Author: Vince Sliwoski Congressman Earl Blumenauer (D-Oregon) is retiring next month. Mr. Blumenauer, or “Earl” as he often asked to be called, has been a leading proponent of cannabis reform since 1973, when Oregon was the first…
Author: Vince Sliwoski Congressman Earl Blumenauer (D-Oregon) is retiring next month. Mr. Blumenauer, or “Earl” as he often asked to be called, has been a leading proponent of cannabis reform since 1973, when Oregon was the first…
Recent enforcement by the Australian Therapeutic Goods Administration (TGA) indicates that the regulator is actively monitoring and taking legal action against businesses and individuals that it considers are engaging in the…
On May 16, 2024, the U.S. Department of Justice announced that the Attorney General has submitted a notice of proposed rulemaking initiating a formal rulemaking process…
On April 30, 2024, the Department of Justice submitted a formal proposal to the White House to loosen the restrictions placed on marijuana and formally recognize its medical use.
After an expected Drug Enforcement Agency reclassification, under federal law, cannabis will move from Schedule I to Schedule III. Currently, cannabis is listed under Schedule I, a category of drugs like heroin and LSD “with no…
Daniel is a Seattle-based corporate and regulatory attorney who works extensively with entrepreneurs in the cannabis industry. He advises clients on matters related to both hemp and marijuana and frequently speaks on legal issues…
At the state level, efforts to legalize cannabis—for both medical and recreational use—are already well underway. While cannabis remains fully illegal in many states, most states have now legalized medical cannabis in some form,…
But there is one aspect of this regulatory rigmarole that is semi-transparent: the “Unified Agenda” of Office of Information and Regulatory Affairs (OIRA). OIRA is an office within the Office of Management and Budget (OMB) that…
Cannabis industry participants are keeping close tabs on a potential breakthrough in the Virginia recreational cannabis market. Virginia legalized adult-use recreational cannabis in 2021, but legislation that would have allowed…
On December 12, 2023, the Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation (MAPS PBC) announced their submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for…
BY AARON PELLEY ● SEPTEMBER 28, 2023 As cannabis legalization and further medical implementation of the cannabis plant becomes more legal and accessible, the discussion surrounding the possible medicinal benefits behind other…